Solifenacin: all 99 studies that test it

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Melatonin and Solifenacin for Double-J Ureteral Stent SymptomsRecruitingNCT07617922Phase 2
• The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled TrialNot yet recruitingNCT07114640Phase 3
• Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related SymptomsRecruitingNCT06803030Phase 3
• Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)RecruitingNCT06551246Phase 3
• Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive BladderRecruitingNCT06479720Phase 4
• Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor OveractivityRecruitingNCT06197295Phase 4
• Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus SolifenacinRecruitingNCT04023253Phase 3
• Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsRecruitingNCT01530373Phase 2
• Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson DiseaseCompletedNCT03149809Phase 3Results posted
• A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's TypeCompletedNCT02549196Phase 2Results posted
• A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive BladderCompletedNCT02045862Phase 3Results posted
• A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)CompletedNCT01981954Phase 3Results posted
• This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive BladderCompletedNCT01972841Phase 3Results posted
• A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)CompletedNCT01908829Phase 3Results posted
• VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the ProstateTerminatedNCT01777217Phase 4Results posted
• A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder PatientsCompletedNCT01745094Phase 4Results posted
• A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076CompletedNCT01655069Phase 3Results posted
• Bacterial Genomic Sequencing in Overactive BladderCompletedNCT01642277Phase 2Results posted
• A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active DrugCompletedNCT01565707Phase 3Results posted
• A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor OveractivityCompletedNCT01565694Phase 3Results posted
• Incontinence & Intimate Partners: Assessing the Contribution of TreatmentCompletedNCT01559389Phase 4Results posted
• The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)CompletedNCT01533597Phase 4Results posted
• The Effect of Solifenacin on Post Void Dribbling in WomenCompletedNCT01470001Not applicableResults posted
• Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract SymptomsCompletedNCT01457573Phase 4Results posted
• Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract SymptomsCompletedNCT01381120Phase 4Results posted
• A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical ProstatectomyCompletedNCT01371994Phase 4Results posted
• A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive BladderCompletedNCT01340027Phase 2Results posted
• Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)CompletedNCT01215721Not applicableResults posted
• A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental AbilityCompletedNCT01126424Phase 4Results posted
• Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.CompletedNCT01093534Phase 4Results posted
• Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow ParametersCompletedNCT01028014Not applicableResults posted
• Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract SymptomsCompletedNCT01021332Phase 3Results posted
• Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract SymptomsCompletedNCT01018511Phase 3Results posted
• Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's DiseaseCompletedNCT01018264Phase 4Results posted
• Validation of a Real-time Urodynamic Measure of Urinary UrgencyCompletedNCT00909428Phase 4Results posted
• Over Active Bladder Patients Having Sling SurgeryTerminatedNCT00852696Not applicableResults posted
• Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive BladderTerminatedNCT00821184Phase 3Results posted
• Feasibility of "At-home" Titration of SolifenacinTerminatedNCT00759577Phase 4Results posted
• Study to Determine Effects of Vesicare on Return to Continence Post- Radical ProstatectomyTerminatedNCT00581061Not applicableResults posted
• Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of LifeCompletedNCT00573508Phase 4Results posted
• Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet ObstructionCompletedNCT00507455Phase 2Results posted
• Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)CompletedNCT00431041Phase 4Results posted
• Double j Stent Related SymptomsCompletedNCT07447518Early Phase 1
• Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.CompletedNCT07114848Phase 4
• Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic BiomarkerCompletedNCT06489951Not applicable
• Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)Active, not recruitingNCT06465576Phase 4
• Management of OAB in Female Patients .CompletedNCT06184334Not applicable
• Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive BladderCompletedNCT06024005Not applicable
• IDB Injection Combined With PTNS for Managing Children With OAB Not Responding to MonotherapyCompletedNCT05911594Not applicable
• Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple SclerosisTerminatedNCT04819360Phase 4
• Efficacy of Biofeedback PFMT and Medication in Women With Overactive BladderCompletedNCT04477265Not applicable
• Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPOCompletedNCT04437108Not applicable
• Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related SymptomsStatus unknownNCT04325880Phase 3
• Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB SymptomsCompletedNCT04064619Not applicable
• Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURPStatus unknownNCT03632772Phase 2
• Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male VolunteersCompletedNCT02940314Phase 1
• Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate HyperplasiaStatus unknownNCT02827578Phase 3
• Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder SymptomsCompletedNCT02715024Phase 4
• Reproducibility Study of OABSS and Its Response to TreatmentCompletedNCT02667470Phase 4
• EC905 Pharmacokinetic Profile StudyCompletedNCT02634489Phase 1
• The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.CompletedNCT02494349Phase 1
• Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and TamsulosinCompletedNCT02180997Phase 1
• Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male SubjectsCompletedNCT02169713Phase 1
• Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy SubjectsCompletedNCT02127034Phase 1
• The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in FemalesStatus unknownNCT02094703Phase 4
• A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose LevelsCompletedNCT02010944Phase 1
• A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and TamsulosinCompletedNCT01953887Phase 1
• Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent SymptomsCompletedNCT01880619Phase 4
• Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB PatientsStatus unknownNCT01876186Phase 4
• Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)CompletedNCT01747577Phase 4
• Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic DrugStatus unknownNCT01627145Not applicable
• Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency SymptomsStatus unknownNCT01595152Not applicable
• Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive BladderCompletedNCT01539707Phase 1
• A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary IncontinenceCompletedNCT01505439Phase 4
• Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder SyndromeCompletedNCT01503580Not applicable
• Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive BladderStatus unknownNCT01423838Phase 4
• A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet FormulationCompletedNCT01406158Phase 1
• A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin TreatmentCompletedNCT01318837Phase 4
• A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin SimultaneouslyCompletedNCT01297192Phase 1
• Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and AdolescentsCompletedNCT01262391Phase 1
• Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal ProlapseTerminatedNCT01092624Phase 4
• Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy VolunteersCompletedNCT01015040Phase 1
• Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without UrgencyCompletedNCT00979472Phase 4
• A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 WeeksCompletedNCT00884104Phase 4
• Solifenacin Succinate Versus Tolterodine 4mg Once DailyCompletedNCT00802373Phase 3
• Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency SymptomsCompletedNCT00801944Phase 3
• Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive BladderWithdrawnNCT00773552Phase 4
• Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic HyperplasiaCompletedNCT00771394Phase 4
• A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive BladderCompletedNCT00699049Phase 4
• Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple SclerosisCompletedNCT00629642Phase 4
• Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's DiseaseWithdrawnNCT00584090Phase 4
• A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPHCompletedNCT00510406Phase 2
• Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder SymptomsCompletedNCT00463541Phase 3
• A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)CompletedNCT00454896Phase 3
• Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive BladderCompletedNCT00454740Phase 3
• A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder PatientsCompletedNCT00368706Phase 3
• A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)CompletedNCT00337558Phase 4
• A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.CompletedNCT00333112Phase 4
• A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive BladderCompletedNCT00189800Phase 3

← Solifenacin overview